This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Ratings

10 Best Life Sciences Stocks for

Top Rated Stocks

Every day TheStreet Ratings produces a list of the top rated stocks. These 10 life sciences stocks are rated highest by our methodology.

Equity Top: Life Sciences Tools & Services


Source: TheStreet Ratings

Best Investments for

Life Sciences

Pharmaceutical veteran Carrie Cox was highlighted by TheStreet as a great addition to any board of directors. She shares her thoughts on what it means to be a good director.
4/30/16 10:27AM
Doug Kass invokes Elaine from 'Seinfeld' to describe China's data and finds Starbucks not quite good to the last drop
4/29/16 11:02AM
Jim Cramer looks carefully and prefers the companies over German data, and considers papers and plastics in China.
4/29/16 10:51AM
The San Francisco target rejects the $9.3 billion offer, but biotech growth and a healthy pipeline mean Sanofi isn't desperate for Medivation's cancer treatments.
4/29/16 10:50AM
Benchmark indices slip after better-than-forecast data on first-quarter GDP but disappointing news on Eurozone consumer prices.
4/29/16 5:44AM
The following THERMO FISHER SCIENTIFIC INC (TMO) conference call took place on April 28, 2016, 08:30 AM ET. This is a transcript of that earnings call:
4/28/16 7:10PM
The following BRISTOL-MYERS SQUIBB CO (BMY) conference call took place on April 28, 2016, 10:30 AM ET. This is a transcript of that earnings call:
4/28/16 6:37PM
The following United Therapeutics (UTHR) conference call took place on April 28, 2016, 09:00 AM ET. This is a transcript of that earnings call:
4/28/16 2:30PM
Thursday's parade of deals seem to answer a question that's been bugging health care investors for most of 2016: why haven't retreating biotech valuations sparked an uptick in M&A activity?
4/28/16 1:30PM
Gilead Sciences (GILD) shares are slumping on Thursday morning ahead of the company's 2016 first quarter results set to be released this afternoon.
4/28/16 10:38AM
Senior FDA officials, most notably Dr. Janet Woodcock, the agency's top drug evaluator, spent a lot of time at Monday's panel making supportive statements about eteplirsen.
4/28/16 10:17AM
The following Vertex Pharmaceuticals (VRTX) conference call took place on April 27, 2016, 05:30 PM ET. This is a transcript of that earnings call:
4/28/16 8:14AM
The French pharmaceuticals company takes its campaign to snare the oncology specialist public.
4/28/16 7:00AM
Deutsche Bank jumps on brighter-than-expected first-quarter numbers but the prospect of order delays grounds shares in Airbus.
4/28/16 5:25AM
Vertex Pharmaceuticals tried to soothe fears about the commercial ramp of its cystic fibrosis franchise by providing Orkambi sales guidance for the first time since the drug launched last summer.
4/27/16 5:03PM

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Markets

Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%
Top Rated Stocks Top Rated Funds Top Rated ETFs